Changing Diagnostic Criteria Did Not Expand Cannabis Dependence Uniformly in a Historical Comparison

A historical comparison of DSM-III and DSM-III-R diagnoses found that neither system consistently predominated for cannabis dependence. Changes that expanded diagnoses for some other substances did not necessarily produce the same pattern for cannabis.

The study compared classifications in the same setting

Recent admissions to drug-treatment centers were interviewed with an instrument covering criteria from both systems. Investigators examined agreement, overlap and positive agreement by substance. These measures assess correspondence between classification systems, rather than the biological presence of a drug or impairment at a particular time.

Results differed across substances

The abstract reports a wider dependence classification under DSM-III-R for alcohol, tobacco and amphetamines, but no predominating system for cannabis, opioids or sedative-related categories. A general statement that the revision simply increased every substance diagnosis would therefore be unsupported.

Historical labels cannot be substituted for current criteria

This was a comparison of older diagnostic systems in a treatment-seeking population. It does not establish the prevalence of a current cannabis diagnosis in the general public. Nor can a toxicology result alone determine which interview-based criteria a person met. Drug detection and longitudinal clinical assessment address different evidence.

Interpreting the evidence

When comparing cannabis diagnoses across studies, retain the criteria edition, instrument and population. Apparent changes in diagnostic counts can reflect how a category was defined as well as changes in the people assessed.

Related reading: separate functional and structural endpoints in cannabinoid research.

Research reference

Cottler LB; Helzer JE; Mager D; et al. (1991). Agreement between DSM-III and III-R substance use disorders. Drug and alcohol dependence. doi:10.1016/0376-8716(91)90018-t. Evidence basis: report abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Admission Samples in a Residual-THC Study Were Not Automatically Baseline Measurements

The first sample collected after admission to detoxification is not automatically a stable residual-THC baseline. In a study of heavy cannabis users, some participants had smoked only an hour or two before entering treatment. The investigators explicitly cautioned against treating every first-day result as a baseline concentration. Admission and last…

Spread the love

Read Article: Admission Samples in a Residual-THC Study Were Not Automatically Baseline Measurements

An Endogenous Pain Pathway Worked Independently of Endocannabinoid Mechanisms in Rodents

A rodent study found pain-related benefits from activating an endogenous adenosine pathway independently of opioid and endocannabinoid mechanisms. Endogenous pain modulation is therefore not automatically evidence of cannabinoid-receptor involvement. The intervention targeted adenosine signaling Researchers increased endogenous adenosine through kinase inhibition and separately tested a selective A3-receptor agonist. Receptor blockade…

Spread the love

Read Article: An Endogenous Pain Pathway Worked Independently of Endocannabinoid Mechanisms in Rodents

Cannabis in a Mixed-Drug Fatality Series: Hair and Blood Answer Different Exposure Questions

A Danish methadone-fatality study reported extensive mixed-drug exposure, including cannabis, and used segmental hair analysis to extend the exposure history beyond blood testing. That additional history was not proof of simultaneous intoxication from every listed substance. The two matrices supplied different information The study examined fatalities with both blood and…

Spread the love

Read Article: Cannabis in a Mixed-Drug Fatality Series: Hair and Blood Answer Different Exposure Questions

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us